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Inflammatory Bowel Disease (IBD) is a chronic and relapsing inflammatory disorder of
the gastrointestinal tract. Crohn’s Disease (CD) and Ulcerative Colitis (UC) are the two most
common forms of IBD, marked by periods of disease flare and remission. IBD is affecting
a growing number of children, with peak onset occurring during adolescence. In the
United States, the incidence of pediatric IBD is approximately 10 out of 100,000 children [1].
As the prevalence of pediatric IBD rises, so does the importance and urgency of better
understanding and holistically treating IBD.
The pathophysiology of IBD is thought to be multifactorial and involve a complex
interaction between genetic factors, the immune system, gut microbiota, nutrition, and psychosocial factors. A deeper understanding of the connection between the brain and the gut
has also shed light on how the brain–gut axis may impact IBD. Research has demonstrated
that psychological factors can influence the gut through the central nervous system, and
modulation of gut stimuli and hypothalamic–pituitary–adrenal axis, and the gut is thought
to impact the brain primarily via the gut microbiota-inflammatory pathway [2,3]. Of note,
studies have demonstrated that psychosocial factors (e.g., depression) have been shown to
be strong predictors of negative health outcomes in pediatric IBD, such as disease activity
and risk of relapse, as well as nonadherence, healthcare utilization, and higher health care
costs [4,5]. There is also preliminary evidence that inflammatory activity is associated
with the development of psychiatric disorders [6,7]. Additionally, children with IBD are at
increased risk for emotional/behavioral challenges and poorer quality of life compared to
healthy children and youth with other chronic health conditions, and these challenges have
shown strong links to poor health outcomes [8–11]. While additional research is needed
to better understand the complex bidirectional relationship between inflammatory activity and psychological functioning in IBD, studies to date have highlighted that children
with IBD are a high-risk population that could benefit from integrated care addressing
intersecting biological, psychological, and social needs.
An integrated multidisciplinary care model for the treatment of pediatric IBD joins
gastroenterologists with mental health providers and other subspecialties to provide comprehensive patient care from a biopsychosocial perspective. Each provider is recognized
as an expert and collaborator who is vital in providing patient treatment. The goal and
benefit of such holistic treatment plans is that providers work jointly, and in parallel, with
each other and families to prioritize disease management, functioning across domains, and
the wellbeing of children with IBD at all stages of disease. This care model is increasingly
common and deemed essential for optimal care. Multidisciplinary treatment teams that
combine the expertise of gastroenterologists, surgeons, nurses, dieticians, psychologists,
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and social workers collaboratively develop individualized and comprehensive treatment
plans that support the whole child and family.
One size does not fit all in integrated multidisciplinary care models. What works
for one pediatric practice may not be successful for another pediatric practice. Clinicians
are encouraged to individualize integrated care models to the specific needs of patients,
with consideration given to the specific setting, patient population, and resources of the
practice. One example of an integrated health care model is the IBD Clinic at Children’s
Mercy-Kansas City, established in 2011. This clinic uses a multidisciplinary team approach
in the assessment and treatment of children and adolescents with IBD, and is staffed by
medical, psychology, and affiliated healthcare professionals (e.g., dietician, social worker,
pharmacist) most of whom are dedicated entirely to this patient population. Patients are
seen by the interdisciplinary team within one to four weeks of their initial IBD diagnosis
with once yearly follow-up thereafter with the team for continuity of care. Routine medical
care between these yearly visits to the IBD Clinic is provided by each patient’s primary
gastroenterologist. As part of the standard clinical care during these visits, patients and
caregivers complete psychosocial questionnaires on the patient’s emotional/behavioral
functioning, quality of life, and adherence. This routine screening allows the team to monitor a patient’s psychosocial functioning over time and proactively target any functional
changes before they develop into clinically significant psychosocial difficulties. Another integrated IBD clinic at Children’s Mercy-Kansas City, which began in 2017, is a Young Adult
IBD Clinic. It is staffed by a multidisciplinary team comprised of an APRN, pharmacist,
psychologist and social worker, and is focused on transition planning, self-management
and self-advocacy among young adult patients. As part of standard practice in this clinic,
patients and caregivers complete questionnaires on self-efficacy, transition readiness, perceived transition barriers, and allocation of treatment responsibility. This information is
reviewed by the team collaboratively and used to guide the content of the visit. Patients are
seen in the Young Adult IBD Clinic one to four times per year, depending on the patient’s
age and transition preparedness.
Stanford Children’s IBD Center is another program that employs an integrated team
approach in the evaluation and treatment of children with IBD. The primary team is
comprised of IBD gastroenterologists, nurses/nurse practitioners, and a psychologist,
social worker, dietician, and research and clinic coordinator. Since 2017, newly diagnosed
patients have been seen by the IBD team approximately one to three months after diagnosis
to provide a comprehensive evaluation and determine the various services that children
and families may need, from medical to psychosocial and nutritional support. Patients
and caregivers also complete medical, psychosocial, and dietary questionnaires at this
visit to assess important IBD-related outcomes and highlight any clinical or functional
challenges that should be a target of the visit, as well as patients’ strengths and wellbeing.
While patients are primarily followed by an IBD gastroenterologist or nurse practitioner,
many patients and families continue to receive integrated IBD treatment and support from
a dietician, social worker, and/or psychologist. Common examples of this integrated
care include supporting a child who is struggling with mood, anxiety, or adjustment
challenges related to IBD, nonadherence to medical and/or dietary therapies, or persistent
pain. Additionally, Stanford Children’s IBD Center has specialized interdisciplinary clinics
focused on IBD integrative medicine, IBD nutrition, and IBD transition (from pediatric to
adult care) staffed by medical providers and affiliated healthcare providers.
Our colleagues, who have similarly developed notable integrated IBD programs at
their respective institutions, are highlighted in this Special Issue.
Building an integrated pediatric IBD program is an iterative and thoughtfully constructed process. Our collaborative endeavors in pediatric IBD care have highlighted that
one of the most frequently reported challenges when building an integrated IBD program
is the absence of multidisciplinary care providers, most notably psychologists and social
workers. In fact, the question, “How do we secure psychosocial providers on our team?”
is a common and important one. Addressing this issue often necessitates a process of
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demonstrating the value added by integrating psychosocial providers in the routine care
of young patients with IBD. This might involve a period of data collection to show the
unmet needs of patients in the absence of a psychologist and social worker; for example,
the proportion of patients with psychosocial needs who cannot easily access necessary
resources in the community, the impact of such unmet psychosocial needs on IBD-related
health outcomes, and the amount of time providers spend addressing psychosocial needs
during routine visits. Of equal importance is the process of demonstrating the positive impact of integrated psychosocial care on health outcomes and drawing on the research base
to strengthen this argument. Such data can be invaluable when leveraging institutional
support to secure psychologists and social work providers in the care of IBD patients.
Training the next generation of pediatric gastroenterologists to practice within a biopsychosocial framework is an approach that warrants strong consideration and has relevance
to practice across the developmental lifespan of a gastroenterology professional. Curricula
for education and training should be developed to incorporate behavioral medicine into GI
fellowship training (i.e., integration of behavioral, psychosocial, and biomedical science
knowledge in the prevention, diagnosis, and treatment of illness), meet key competencies,
and address behavioral-medicine-relevant information in the required American Board
of Pediatrics board exams. It is widely recognized that integrated care can improve patients’ quality of life and health outcomes, as well as reduce overall health care costs and
utilization. The North American Society for Pediatric Gastroenterology, Hepatology, and
Nutrition (NASPGHAN) has published training guidelines that emphasize the importance
of a biopsychosocial paradigm and integrated care [12], but such models have not yet
emerged as the practice standard. As such, the training of GI professionals remains a top
priority to further the application of integrated multidisciplinary care models.
This Special Issue, “Integrated Multidisciplinary Care for Pediatric Inflammatory
Bowel Disease: Supporting Disease and Psychosocial Outcomes,” is dedicated to describing
the evidence for, and application of, integrated biopsychosocial IBD care. It contains a
collection of manuscripts written by expert clinicians and researchers in the field of IBD.
We hope that this Special Issue educates others, highlights the importance and value of
integrated multidisciplinary care in the field of pediatric IBD, and supports the growth of
such programs nationally.
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